Target intelligence / Profile preview

Collectin liver 1 (CL-L1)

Target
CL-L1
Molecular classification
Soluble pattern recognition molecule, Collectin family (C-type lectin), C-type lectin family, Secreted glycoprotein
01

Overview

Collectin liver 1 (CL-L1, encoded by the COLEC10 gene) is a **soluble pattern recognition protein** of the collectin family, specifically a **C-type lectin** that contains collagen-like sequences and carbohydrate recognition domains[6][8]. CL-L1 plays a key role in the **lectin complement pathway**, contributing to the recognition and removal of pathogens and regulation of cell migration during embryonic development—especially of neural crest cells, with implications for facial, cranial, and other tissue morphogenesis[1][3][8]. Mutations in COLEC10 cause **3MC syndrome**, a disorder with diverse developmental defects[1][3][8]. Recent research suggests that CL-L1 also has **tumor suppressor functions** in hepatocellular carcinoma by inhibiting cell proliferation, migration, and EMT, likely via PI3K-AKT, Hedgehog, and p53 signaling pathways[2]. While it is essential for several physiological processes, CL-L1 is not considered a classical drug target (such as a receptor or enzyme), but may serve as a **prognostic biomarker for cancer** and a molecular marker of certain rare genetic syndromes[2][8].

Other names
Collectin-10COLEC10CLL1UNQ366/PRO702CL-L1CL-34Collectin-34collectin liver 1collectin liver protein 1collectin sub-family member 10 (C-type lectin)3MC3collectin-10
02

Biological functions

Lectin complement pathway initiationCell migration during developmentCarbohydrate binding on microorganisms (immune recognition)Regulation of extracellular matrix (ECM) production and alterationImmune response in the innate immune systemRegulation of epithelial-mesenchymal transition (EMT) and cell cycle in hepatic cells
03

Disease associations

3MC syndrome (developmental disorder)Tumor suppressor role in hepatocellular carcinoma (HCC)
04

Biomarkers

Potential prognostic biomarker for hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on Collectin liver 1 (CL-L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collectin liver 1 (CL-L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call